Furthermore, these PDZ-2 domain mutations in DLG1 seem to disable its interaction with the tumor suppressors APC and PTEN, emphasizing the importance of DLG1 functions and how alterations in its protein expression and localization might contribute to the process of oncogenesis [31,32]. The gene discussed is PTEN; the disease is neoplasm.